Macrogenics (MGNX) EBT Margin Growth (3y) (2015 - 2026)
Macrogenics (MGNX) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Macrogenics |
260.14 Mn |
193.63 Mn |
- |
-2,495.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,495.00 |
| Dec 31, 2025 |
-5,261.00 |
| Sep 30, 2025 |
8,289.00 |
| Jun 30, 2025 |
-176.00 |
| Mar 31, 2025 |
27,649.00 |
| Dec 31, 2024 |
37,546.00 |
| Sep 30, 2024 |
38,918.00 |
| Jun 30, 2024 |
-155,583.00 |
| Mar 31, 2024 |
-29,899.00 |
| Dec 31, 2023 |
-44,954.00 |
| Sep 30, 2023 |
-14,350.00 |
| Jun 30, 2023 |
-11,462.00 |
| Mar 31, 2023 |
97,658.00 |
| Dec 31, 2022 |
16,983.00 |
| Sep 30, 2022 |
14,267.00 |
| Jun 30, 2022 |
33,928.00 |
| Mar 31, 2022 |
-10,746.00 |
| Dec 31, 2021 |
-14,776.00 |
| Sep 30, 2021 |
23,552.00 |
| Jun 30, 2021 |
10,433.00 |
